The fact that its tested and made in the U.S
Dihexa did not alter aminoglycoside entry into hair cells but attenuated cell death through HGF-dependent intracellular signaling, with downstream contributions from the Akt, mTOR, and MEK pathways
Importantly, information regarding the indications, dosing, frequency, and duration of treatment remains unknown
For example, a musculoskeletal model might follow changes in tissue histology and movement patterns, while a gut-focused model could track barrier integrity, local signaling markers, or microbiome shifts
BPC-157 has been shown to be effective in treating various medical conditions, such as inflammatory bowel disease (IBD), muscle damage, ulcerative colitis, gastric ulcers, and tendonitis
Third party testing eliminates potential conflicts of interest in quality assessment